Stay updated on ALT-801 Efficacy in Obesity Clinical Trial
Sign up to get notified when there's something new on the ALT-801 Efficacy in Obesity Clinical Trial page.

Latest updates to the ALT-801 Efficacy in Obesity Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record describes a completed Phase 2 study evaluating ALT-801 for obesity, including its design, outcome measures, eligibility criteria, and participating locations. It indicates that the study is no longer recruiting participants.SummaryDifference58%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedAn NIH-wide banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content. It appears above the blocked study record.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error. It replaces the study content with a generic header and footer, indicating the page is inaccessible.SummaryDifference17%

Stay in the know with updates to ALT-801 Efficacy in Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 Efficacy in Obesity Clinical Trial page.